Skip to main content
Log in

Ocular Pharmacokinetic/Pharmacodynamic Modeling for Bunazosin After Instillation into Rabbits

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To develop a pharmacokinetic/pharmacodynamic (PK/PD) model for an α1-blocker (bunazosin) after instillation. The PK/PD model can predict both the drug concentrations in various ocular tissues and the hypotensive effect.

Methods. Bunazosin concentrations were determined with High Performance Liquid Chromatography (HPLC) in tear fluid, the aqueous humor, cornea, and iris-ciliary body after instillation or ocular injection into the anterior chamber in rabbits. After instillation of bunazosin in rabbits, intraocular pressure (IOP) was also determined with a pneumatic tonometer. The PK/PD parameters were estimated by fitting the concentration-time profiles and the hypotensive effect-time profiles to the developed PK/PD models using the MULTI (RUNGE) program.

Results. On the basis of the concentration-time profiles of bunazosin, a PK model, including seven compartments, was developed for examining the behavior of bunazosin after instillation. Then, two PK/PD models for hypotensive effect of bunazosin were developed using an indirect response (model A) and the relationship between IOP and aqueous humor flow (model B). These models well described the concentration-time profiles and hypotensive effect-time profiles of bunazosin after instillation.

Conclusions. This study is the first trial to develop a PK/PD model for an antiglaucoma agent using an indirect response and the relationship between IOP and aqueous humor flow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

references

  1. H. Sasaki, K. Yamamura, T. Mukai, K. Nishida, J. Nakamura, M. Nakashima, and M. Ichikawa. Enhancement of ocular drug penetration. Crit. Rev. Ther. Drug Carrier Syst. 16:85-146 (1999).

    Google Scholar 

  2. K. Yamamura, H. Sasaki, M. Nakashima, M. Ichikawa, T. Mukai, and K. Nishida. and J. Nakamura. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation. Pharm. Res. 16:1596-1601 (1999).

    Google Scholar 

  3. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiodyn. 4:879-885 (1981).

    Google Scholar 

  4. M. Sakurai, M. Araie, T. Oshika, M. Mori, N. Shoji, and K. Masuda. Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit. Jpn. J. Ophthalmol. 37:252-258 (1993).

    Google Scholar 

  5. K. Yamaoka and T. Nakagawa. A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J. Pharmacobiodyn. 6:595-606 (1983).

    Google Scholar 

  6. T. Takagi, N. Sun, Y. Kuwayama, R. Yamamoto, M. Tanaka, T. Kusunoki, Y. Shimizu, and R. Manabe. The effect of bunazosin hydrochloride on intraocular pressure and aqueous humor dynamics in human. Acta Soc. Ophthalmol. Jpn. 95:273-278 (1991).

    Google Scholar 

  7. G. L. Zhan, C. B. Toris, C. B. Camras, Y. L. Wang, and M. E. Yablonski. Bunazosin reduces intraocular pressure in rabbits by increasing uveoscleral outflow. J. Ocul. Pharmacol. Ther. 14:217-228 (1998).

    Google Scholar 

  8. N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokinet. Biopharm. 21:457-478 (1993).

    Google Scholar 

  9. J. M. Conrad and J. R. Robinson. Aqueous chamber drug distribution volume measurement in rabbits. J. Pharm. Sci. 66:219-224 (1977).

    Google Scholar 

  10. S. F. Nilsson. The uveoscleral outflow routes. Eye 11:149-154 (1997).

    Google Scholar 

  11. K. Nishimura, E. Shirasawa, M. Kinoshita, M. Hikida, and Y. Kuwayama. Ocular hypotensive effects of topically applied bunazosin, an α1-adrenoceptor blocker, in rabbits and cats. Acta Soc. Ophthalmol. Jpn. 95:746-751 (1991).

    Google Scholar 

  12. M. C. Makoid and J. R. Robinson. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye. J. Pharm. Sci. 68:435-443 (1979).

    Google Scholar 

  13. R. D. Schoenwald. Ocular drug delivery. Pharmacokinetic considerations. Clin. Pharmacokinet. 18:255-269 (1990).

    Google Scholar 

  14. A. Kato and S. Iwata. Corneal permeability to bunazosin in rabbits. J. Pharmacobiodyn. 11:181-185 (1988).

    Google Scholar 

  15. H. Derendorf and B. Meibohm. Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm. Res. 16:176-185 (1999).

    Google Scholar 

  16. Y. Kimoto, M. Nozaki, and T. Itoh. Actions of the alpha-1 adrenoceptor blocker bunazosin on the norepinephrine-induced contraction of smooth muscles in the rabbit proximal urethra. J. Pharmacol. Exp. Ther. 241:1017-1022 (1987).

    Google Scholar 

  17. Y. Yamada, K. Matsuyama, K. Ito, Y. Sawada, and T. Iga. Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy. J. Pharmacokinet. Biopharm. 23:463-478 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hitoshi Sasaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakanaka, K., Kawazu, K., Tomonari, M. et al. Ocular Pharmacokinetic/Pharmacodynamic Modeling for Bunazosin After Instillation into Rabbits. Pharm Res 21, 770–776 (2004). https://doi.org/10.1023/B:PHAM.0000026426.20012.36

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000026426.20012.36

Navigation